Amended Current Report Filing (8-k/a)
October 12 2022 - 5:16PM
Edgar (US Regulatory)
0001851860
true
0001851860
2022-07-29
2022-07-29
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K/A
(Amendment
No. 1)
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): October 12, 2022 (July 29, 2022)
SMART
FOR LIFE, INC. |
(Exact
name of registrant as specified in its charter) |
Delaware |
|
001-41290 |
|
81-5360128 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
990
Biscayne Blvd., Suite 503, Miami, FL |
|
33132 |
(Address of principal executive
offices) |
|
(Zip Code) |
(786)
749-1221 |
(Registrant’s telephone
number, including area code) |
|
(Former
name or former address, if changed since last report) |
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
|
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
☐ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common Stock, par value $0.0001 per share |
|
SMFL |
|
The Nasdaq Stock Market LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2
of the Securities Exchange Act of 1934.
Emerging
Growth Company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
EXPLANATORY
NOTE
On
July 29, 2022, Smart for Life Inc. (the “Company”) acquired all of the issued and outstanding membership interests of
Ceautamed Worldwide, LLC (“Ceautamed”), pursuant to a securities purchase agreement, dated March 14, 2022, among the
Company, RMB Industries, Inc., RTB Childrens Trust and D&D Hayes, LLC, as amended.
This Amendment No. 1 to Current
Report on Form 8-K/A amends the Form 8-K that the Company filed on August 4, 2022 to include the financial statements of the
business acquired as required by Items 9.01(a) and 9.01(b) of Form 8-K.
Item
9.01 Financial Statements and Exhibits.
(a)
Financial Statements of Business Acquired
The
audited consolidated financial statements of Ceautamed for the year ended December 31, 2021 and the accompanying notes thereto are filed
as Exhibit 99.1 attached hereto and are incorporated by reference herein.
The
unaudited consolidated financial statements of Ceautamed for the six months ended June 30, 2022 and the accompanying notes thereto are
filed as Exhibit 99.2 attached hereto and are incorporated by reference herein.
(b)
Pro forma financial information
The
unaudited pro forma combined financial information giving effect to the acquisition is filed as Exhibit 99.3 attached hereto and is incorporated
herein by reference.
(d)
Exhibits
Exhibit No. |
|
Description of Exhibit |
10.1 |
|
Securities Purchase Agreement, dated March 14, 2022, among Smart for Life, Inc., Ceautamed Worldwide, LLC, RMB Industries, Inc., RTB Childrens Trust and D&D Hayes, LLC (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on March 16, 2022) |
10.2 |
|
First Amendment to Securities Purchase Agreement, dated July 29, 2022, among Smart for Life, Inc., Ceautamed Worldwide, LLC, RMB Industries, Inc., RTB Childrens Trust and D&D Hayes, LLC (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed on August 4, 2022) |
10.3 |
|
Secured Subordinated Convertible Promissory Note issued by Smart for Life, Inc. to RMB Industries, Inc. on July 29, 2022 (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed on August 4, 2022) |
10.4 |
|
Secured Subordinated Convertible Promissory Note issued by Smart for Life, Inc. to RTB Childrens Trust on July 29, 2022 (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K filed on August 4, 2022) |
10.5 |
|
Secured Subordinated Convertible Promissory Note issued by Smart for Life, Inc. to D&D Hayes, LLC on July 29, 2022 (incorporated by reference to Exhibit 10.5 to the Current Report on Form 8-K filed on August 4, 2022) |
10.6 |
|
Secured Subordinated Promissory Note issued by Smart for Life, Inc. to RMB Industries, Inc. on July 29, 2022 (incorporated by reference to Exhibit 10.6 to the Current Report on Form 8-K filed on August 4, 2022) |
10.7 |
|
Secured Subordinated Promissory Note issued by Smart for Life, Inc. to RTB Childrens Trust on July 29, 2022 (incorporated by reference to Exhibit 10.7 to the Current Report on Form 8-K filed on August 4, 2022) |
10.8 |
|
Secured Subordinated Promissory Note issued by Smart for Life, Inc. to D&D Hayes, LLC on July 29, 2022 (incorporated by reference to Exhibit 10.8 to the Current Report on Form 8-K filed on August 4, 2022) |
10.9 |
|
Secured Subordinated Promissory Note issued by Smart for Life, Inc. to RMB Industries, Inc. on July 29, 2022 (incorporated by reference to Exhibit 10.9 to the Current Report on Form 8-K filed on August 4, 2022) |
10.10 |
|
Secured Subordinated Promissory Note issued by Smart for Life, Inc. to D&D Hayes, LLC on July 29, 2022 (incorporated by reference to Exhibit 10.10 to the Current Report on Form 8-K filed on August 4, 2022) |
10.11 |
|
Secured Subordinated Promissory Note issued by Smart for Life, Inc. to Bactolac Pharmaceuticals, Inc. on July 29, 2022 (incorporated by reference to Exhibit 10.11 to the Current Report on Form 8-K filed on August 4, 2022) |
10.12 |
|
Secured Subordinated Promissory Note issued by Smart for Life, Inc. to Stuart Benson on July 29, 2022 (incorporated by reference to Exhibit 10.12 to the Current Report on Form 8-K filed on August 4, 2022) |
10.13 |
|
Note Purchase Agreement, dated July 29, 2022, between Smart for Life, Inc. and Joseph X. Xiras (incorporated by reference to Exhibit 10.13 to the Current Report on Form 8-K filed on August 4, 2022) |
10.14 |
|
Original Issue Discount Secured Subordinated Note issued by Smart for Life, Inc. to Joseph X. Xiras on July 29, 2022 (incorporated by reference to Exhibit 10.14 to the Current Report on Form 8-K filed on August 4, 2022) |
10.15 |
|
Form of Debenture Purchase Agreement (incorporated by reference to Exhibit 10.15 to the Current Report on Form 8-K filed on August 4, 2022) |
10.16 |
|
Form of Debenture (incorporated by reference to Exhibit 10.16 to the Current Report on Form 8-K filed on August 4, 2022) |
99.1 |
|
Audited Consolidated Financial Statements of Ceautamed Worldwide, LLC for the Year Ended December 31, 2021 |
99.2 |
|
Unaudited Combined Financial Statements of Ceautamed Worldwide, LLC for the Six Months Ended June 30, 2022 |
99.3 |
|
Unaudited Pro Forma Combined Financial Statements |
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date: October 12, 2022 |
SMART FOR LIFE, INC. |
|
|
|
/s/ Darren C.
Minton |
|
Name: |
Darren C. Minton |
|
Title: |
Chief Executive Officer |
3
Smart for Life (NASDAQ:SMFL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Smart for Life (NASDAQ:SMFL)
Historical Stock Chart
From Apr 2023 to Apr 2024